AI-401: Partner Eli Lilly began the first of three planned Phase II trials

AutoImmune Inc. (AIMM), Lexington, Mass. Product: AI-401, oral recombinant insulin Indication: Type I diabetes Status: Partner Eli Lilly began the first of three planned Phase II trials to demonstrat...